4.4 Article

SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway

Journal

MEDICAL ONCOLOGY
Volume 40, Issue 2, Pages -

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12032-022-01944-0

Keywords

SRC-3; Ovarian cancer; Stemness; Migration; Invasion

Categories

Ask authors/readers for more resources

The study aimed to investigate the role of the SRC-3/TRAF4/PI3K/AKT pathway in ovarian cancer development. It was found that SRC-3 and TRAF4 were upregulated in ovarian cancer cell lines. Silencing of SRC-3 or TRAF4 inhibited cell proliferation, migration, invasion, and stemness, as well as the activation of the PI3K/AKT signaling pathway. However, TRAF4 overexpression reversed the effect of SRC-3 silencing.
Objective Ovarian cancer is the seventh most common cancer in women, and it causes many deaths in women worldwide. Patients with ovarian cancer have a poor prognosis and low survival rate. This study aimed to explore the role of the SRC-3/TRAF4/PI3K/AKT pathway in ovarian cancer development. Methods SRC-3 and TRAF4 expression in ovarian cancer cell lines were assessed using qRT-PCR and western-blotting. The expression of SRC-3 and TRAF4 in ovarian cancer cells was downregulated by transient transfection with sh-RNAs. An MTT assay was performed to evaluate cell proliferation. Cell migration and invasion were measured using a Transwell assay. Cell stemness was detected using a cell spheroidization assay and western blotting. The expression levels of stem cell factors and PI3K/AKT pathway proteins were determined by qRT-PCR and western blot analysis. Results SRC-3 and TRAF4 were upregulated in ovarian cancer cell lines. TRAF4 is a downstream factor of SRC-3, and the protein level of TRAF4 was regulated by SRC-3. SRC-3 knockdown reduced TRAF4 expression. Silencing SRC-3 or TRAF4 inhibited cell proliferation, migration, and invasion, as well as the expression of stem cell factors. Furthermore, sh-TRAF4 as well as treatment with LY294002, the PI3K/Akt inhibitor, inhibited the phosphorylation of Akt and PI3K, thus repressing the activation of PI3K/AKT signaling pathway in ovarian cancer cell lines. However, TRAF4 overexpression reversed the effect of SRC-3 silencing on cell proliferation, migration, invasion, and stemness. Conclusion Our study demonstrated that SRC-3/TRAF4 promotes ovarian cancer cell growth, migration, invasion, and stemness by activating the PI3K/AKT pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available